Foamix Pharmaceuticals

📍 Rehovot, Israel🗓 Founded 2003👥 34 employees💰 Last funded 2003
Pharmaceutical Manufacturing🌐 foamix.com
Website LinkedIn
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2003
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Foamix Pharmaceuticals?
Foamix Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Foamix Pharmaceuticals last raise funding?
The most recent investment in Foamix Pharmaceuticals recorded on gritt.io was in 2003.
When was Foamix Pharmaceuticals founded?
Foamix Pharmaceuticals was founded in 2003.
What industry is Foamix Pharmaceuticals in?
Foamix Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Foamix Pharmaceuticals based?
Foamix Pharmaceuticals is headquartered in Rehovot, Israel.